Neuvotion, a Darien, CT-based early-stage medical device company, raised additional $1.25M in funding.
The round, which brought the total amount to $2.75M, included participation from Northwell Holdings, Topspin Fund, and Long Island Angel Network.
The company intends to use the funds to further expand its team, complete clinical studies, and obtain FDA clearance for its initial product.
Founded by Chad Bouton, Neuvotion is an early-stage medical device company developing solutions for facilitating and restoring movement for patients experiencing impairment from stroke, traumatic injury, and other conditions. Its NeuStim™ technology combines highly targeted neurostimulation and artificial intelligence to accelerate rehabilitation while making physical and occupational therapy more effective and efficient. Neuvotion is planning a multi-site clinical study to begin this year.
FinSMEs
13/04/2023